Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| Horizon | Bear case (−1σ) | Base case | Bull case (+1σ) |
|---|---|---|---|
| 1 Month | $547.42 (-11.5%) | $618.82 | $699.52 (+13.0%) |
| 3 Months | $500.44 (-19.1%) | $618.82 | $765.19 (+23.7%) |
| 6 Months | $458.31 (-25.9%) | $618.82 | $835.54 (+35.0%) |
| 12 Months | $404.71 (-34.6%) | $618.82 | $946.20 (+52.9%) |